669-45-4 Usage
Uses
Used in Medicinal Chemistry:
5-CHLORO-2,3-DIHYDRO-BENZOFURAN-3-YLAMINE HYDROCHLORIDE is used as a building block or intermediate in the synthesis of various pharmaceutical compounds for its potential to contribute to the development of new drugs.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 5-CHLORO-2,3-DIHYDRO-BENZOFURAN-3-YLAMINE HYDROCHLORIDE is utilized as a precursor in the production of drugs that target specific biological pathways or receptors, potentially leading to the creation of novel therapeutic agents.
Used in Research and Development:
5-CHLORO-2,3-DIHYDRO-BENZOFURAN-3-YLAMINE HYDROCHLORIDE serves as a research compound in laboratories, where it is studied for its chemical properties, potential interactions with biological systems, and its role in the discovery of new medicinal agents.
Check Digit Verification of cas no
The CAS Registry Mumber 669-45-4 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 6,6 and 9 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 669-45:
(5*6)+(4*6)+(3*9)+(2*4)+(1*5)=94
94 % 10 = 4
So 669-45-4 is a valid CAS Registry Number.
669-45-4Relevant academic research and scientific papers
NOVEL HETEROARYL IMIDAZOLES AND HETEROARYL TRIAZOLES AS GAMMA-SECRETASE MODULATORS
-
Page/Page column 48-49, (2011/05/06)
Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I; (I) as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
NOVEL PHENYL IMIDAZOLES AND PHENYL TRIAZOLES AS GAMMA-SECRETASE MODULATORS
-
Page/Page column 57, (2010/09/18)
Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula (I) as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed
